Mras genetic variation is associated with atherothrombotic stroke in the Han Chinese population

Journal of Clinical Neurology (Korea)

Volumn 9, Issue 4, 2013, Pages 223-230

  Liu, Hua ^a,d   Huang, Xiao Qin ^b   Yang, Min ^c   Ji, Xun Ming ^b   Du, Xin ^a   Zheng, Jian ^d  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherothrombotic stroke; Genetic variation; Haplotype; Ischemic stroke; Single nucleotide polymorphism

Indexed keywords

EID: 84885071508     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2013.9.4.223     Document Type: Article

References (34)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-1276.
2. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008 371:1612-1623.
3. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007;6:456-464.
4. Chen Z. Report for Third National Retrospective Sampling Mortality Survey. Beijing: Peking Union Medical College Press, 2008.
5. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007 6 149-161.
6. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almah-meed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953-962.
7. Humphries SE, Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004;3:227-235.
8. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fay-ad P, et al. Coronary risk evaluation in patients with transient isch-emic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke As-sociation. Circulation 2003;108:1278-1290.
9. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes FG, Isselbacher EM, McCullough PA, et al. Atherosclerotic Vascular Disease Confer-ence: Writing Group I: epidemiology. Circulation 2004;109:2605-2612.
10. Schunkert H, Götz A, Braund P, McGinnis R, Tregouet DA, Mangino M, et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008;117:1675-1684.
11. Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, Ross-Adams H, et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 2009;65:531-539.
12. Anderson CD, Biffi A, Rost NS, Cortellini L, Furie KL, Rosand J. Chromosome 9p21 in ischemic stroke: population structure and meta-analysis. Stroke 2010;41:1123-1131.
13. Erdmann J, Grosshennig A, Braund PS, König IR, Hengstenberg C, Hall AS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009;41:280-282.
14. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2292-2301.
15. Chen J, Zheng H, Bei JX, Sun L, Jia WH, Li T, et al. Genetic struc-ture of the Han Chinese population revealed by genome-wide SNP variation. Am J Hum Genet 2009;85:775-785.
16. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988;41:105-114.
17. Asplund K, Tuomilehto J, Stegmayr B, Wester PO, Tunstall-Pedoe H. Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl 1988;728:26-39.
18. Bevan S, Dichgans M, Gschwendtner A, Kuhlenbäumer G, Ringel-stein EB, Markus HS. Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls. Stroke 2008;39:1966-1971.
19. Rao R, Tah V, Casas JP, Hingorani A, Whittaker J, Smeeth L, et al. Ischaemic stroke subtypes and their genetic basis: a comprehensive meta-analysis of small and large vessel stroke. Eur Neurol 2009;61: 76-86.
20. Han SW, Kim SH, Lee JY, Chu CK, Yang JH, Shin HY, et al. A new subtype classification of ischemic stroke based on treatment and etio-logic mechanism. Eur Neurol 2007;57:96-102.
21. Kelly TN, Gu D, Chen J, Huang JF, Chen JC, Duan X, et al. Cigarette smoking and risk of stroke in the chinese adult population. Stroke 2008;39:1688-1693.
22. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-committee. J Hypertens 1999;17:151-183.
23. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of dia-betes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Dia-bet Med 1998;15:539-553.
24. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. [Chinese guidelines on preven-tion and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35:390-419.
25. Zhou BF. Effect of body mass index on all-cause mortality and inci-dence of cardiovascular diseases--report for meta-analysis of prospec-tive studies open optimal cut-off points of body mass index in Chi-nese adults. Biomed Environ Sci 2002;15:245-252.
26. Chen C, Lu FC. Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 2004;17 Suppl:1-36.
27. International HapMap Consortium. A haplotype map of the human ge-nome. Nature 2005;437:1299-1320.
28. Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT. Basic statistical analysis in genetic case-control stud-ies. Nat Protoc 2011;6:121-133.
29. Pezzini A. Genetic determinants of juvenile stroke. Thromb Res 2012; 129:330-335.
30. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98.
31. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009;19:519-523.
32. Yoshikawa Y, Satoh T, Tamura T, Wei P, Bilasy SE, Edamatsu H, et al. The M-Ras-RA-GEF-2-Rap1 pathway mediates tumor necrosis fac-tor-alpha dependent regulation of integrin activation in splenocytes. Mol Biol Cell 2007;18:2949-2959.
33. Chi Z, Melendez AJ. Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclero-sis. Cell Adh Migr 2007;1:171-175.
34. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, et al. Genotypes and haplotypes predisposing to myocardial infarc-tion: a multilocus case-control study. Eur Heart J 2004;25:459-467.